These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15838569)

  • 21. The role of endothelial dysfunction to predict the development of allograft coronary artery disease following cardiac transplantation.
    Mudge GH; Yeung A; Selwyn AP; Ganz P
    Trans Am Clin Climatol Assoc; 1992; 103():105-10. PubMed ID: 1413370
    [No Abstract]   [Full Text] [Related]  

  • 22. [Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome].
    Potena L; Ferrara R; Mocarski ES; Lewis DB; Cooke JP; Grigioni F; Coccolo F; Magnani G; Fallani F; Magelli C; Valantine HA; Branzi A
    G Ital Cardiol (Rome); 2007 Feb; 8(2):73-82. PubMed ID: 17402351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Coronary vascular reserve in heart transplantation. Normalization after therapy for rejection].
    Nitenberg A; Tavolaro O; Benvenuti C; Loisance D; Foult JM; Hittinger L; Castaigne A; Cachera JP; Vernant P
    Presse Med; 1991 Nov; 20(40):2053-4. PubMed ID: 1837126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B-cell antibodies and hyperlipidemia.
    Hess ML; Hastillo A; Mohanakumar T; Cowley MJ; Vetrovac G; Szentpetery S; Wolfgang TC; Lower RR
    Circulation; 1983 Sep; 68(3 Pt 2):II94-101. PubMed ID: 6347429
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term complications of cardiac transplantation.
    Miller LW
    Prog Cardiovasc Dis; 1991; 33(4):229-82. PubMed ID: 1994457
    [No Abstract]   [Full Text] [Related]  

  • 26. Coronary artery disease in cardiac transplant recipients.
    Stehbens WE
    Med J Aust; 1996 Feb; 164(4):254-5. PubMed ID: 8604207
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody and complement in transplant vasculopathy.
    Wehner J; Morrell CN; Reynolds T; Rodriguez ER; Baldwin WM
    Circ Res; 2007 Feb; 100(2):191-203. PubMed ID: 17272820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.
    Kittleson MM; Bead V; Fradley M; St John ME; Champion HC; Kasper EK; Russell SD; Wittstein IS; Hare JM
    J Heart Lung Transplant; 2007 May; 26(5):498-503. PubMed ID: 17449420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators.
    Tanaka M; Gunawan F; Terry RD; Inagaki K; Caffarelli AD; Hoyt G; Tsao PS; Mochly-Rosen D; Robbins RC
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1160-7. PubMed ID: 15867794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperlipidemia in children after heart transplantation.
    Singh TP; Naftel DC; Webber S; Dupuis J; Chin C; Spicer R; Schowengerdt KO; Ring WS; Morrow WR;
    J Heart Lung Transplant; 2006 Oct; 25(10):1199-205. PubMed ID: 17045932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statins and cardiac allograft vasculopathy after heart transplantation.
    Kobashigawa JA
    Semin Vasc Med; 2004 Nov; 4(4):401-6. PubMed ID: 15861321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Coronary pathology after heart transplantation].
    Desruennes M; Drobinski G; Chomette G; Autran B; Pavie A; Léger P; Gandjbakhch I; Jault F; Grosgogeat Y; Cabrol C
    Presse Med; 1992 Apr; 21(14):670-5. PubMed ID: 1317962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterotopic vascularized murine cardiac transplantation to study graft arteriopathy.
    Hasegawa T; Visovatti SH; Hyman MC; Hayasaki T; Pinsky DJ
    Nat Protoc; 2007; 2(3):471-80. PubMed ID: 17406609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferation signal inhibitors and cardiac allograft vasculopathy.
    Raichlin E; Kushwaha SS
    Curr Opin Organ Transplant; 2008 Oct; 13(5):543-50. PubMed ID: 19060540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production.
    Win TS; Rehakova S; Negus MC; Saeb-Parsy K; Goddard M; Conlon TM; Bolton EM; Bradley JA; Pettigrew GJ
    Circ Heart Fail; 2009 Jul; 2(4):361-9. PubMed ID: 19808360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular immunoobliterative disease: a common cause of graft failure.
    Reemtsma K
    Transplant Proc; 1989 Aug; 21(4):3706. PubMed ID: 2669281
    [No Abstract]   [Full Text] [Related]  

  • 37. Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathy.
    Miller WL; Edwards BS; Kremers WK; Kushwaha SS; McGregor CG; Daly RC; Jaffe AS
    J Heart Lung Transplant; 2005 Dec; 24(12):2075-8. PubMed ID: 16364852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diabetic cardiopathy].
    Mattioli G
    Cardiologia; 1995 Aug; 40(8):535-9. PubMed ID: 8536280
    [No Abstract]   [Full Text] [Related]  

  • 39. Lessons from cardiac transplantation.
    Harrison DC
    Conn Med; 1975 Jun; 39(6):345-7. PubMed ID: 1095290
    [No Abstract]   [Full Text] [Related]  

  • 40. Reliable noninvasive diagnosis of coronary allograft vasculopathy: is it still wishful thinking?
    Mishra PK
    Eur J Cardiothorac Surg; 2006 May; 29(5):862-3; author reply 863-4. PubMed ID: 16520039
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.